Eli Lilly and OpenAI forge pioneering alliance to combat antimicrobial resistance
Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for the discovery of new antimicrobials, aiming to tackle the critical issue of antimicrobial resistance (AMR). This initiative marks a significant advancement in the pharmaceutical industry’s efforts against one of the most daunting health challenges today. Antimicrobial resistance […]